• Wrong document? Swap it for free
  • Written by students who passed
  • Immediately available after payment
  • Read online or as PDF
Sell
Where do you study
Your language
Document preview thumbnail
Preview 4 out of 43 pages
Exam (elaborations)

ABIM Internal Medicine Board Treatable Cancers & Hematology Question Bank 2026/2027 with Verified Answers & Detailed Rationales

Document preview thumbnail
Preview 4 out of 43 pages

This comprehensive question bank is the definitive resource for physicians preparing to successfully conquer the Treatable Cancers and Hematology sections of the ABIM Internal Medicine Board Certification Exam. Featuring a complete collection of high-yield, exam-aligned questions, this bank thoroughly covers all core oncology and hematology topics including hematologic malignancies, solid tumor management, chemotherapy and targeted therapy, anemia, coagulation disorders, and bone marrow disorders. Each question is carefully constructed to reflect the current ABIM exam format and challenge your diagnostic and treatment decision-making abilities. What sets this question bank apart is the detailed answer key providing verified answers with clear, concise rationales for every option. These rationales reinforce essential oncology and hematology concepts, explain the underlying pathophysiology and pharmacology, and guide you in differentiating between competing management strategies under timed exam conditions. Consistent use of this resource will build your test-taking confidence, identify knowledge gaps for focused remediation, and ensure you are fully prepared to achieve a passing score on your first attempt. This is an indispensable tool for any physician committed to board certification success and excellence in internal medicine practice. Vertical Keywords ABIM Internal Medicine Treatable Cancers Hematology Board Review ABIM Question Bank Oncology Hematologic Malignancies Chemotherapy Anemia Coagulation Disorders ABIM Exam Prep Internal Medicine Certification

Content preview

AMERICAN BOARD OF INTERNAL MEDICINE · ABIM
GUARANTEED

PASS.
Treatable Cancers &
Hematology Review
80 Practice Questions with Rationales



EXAM FOCUS:

Oncology & Hematology
— Board Review


Edition 1 · August 2026



Prepare · Practice · Pass

Excellence in Internal Medicine Education
EXAM DETAILED HIGH-YIELD CONFIDENCE
FOCUSED RATIONALES CONTENT BUILDER



ABIM — Treatable Cancers Page 1

,ABIM — TREATABLE CANCERS TABLE OF CONTENTS



Table of Contents

1. Instructions for Use 3

2. Practice Questions (Q1-80) 3


ABIM — Treatable Cancers Page 2

,ABIM — TREATABLE CANCERS INSTRUCTIONS & PRACTICE QUESTIONS




How to Use This Guide
Read each stem, choose your answer, then check the rationale directly below it. The correct
option is marked, and each wrong option is explained so you understand why it's wrong — not
just that it is. This guide contains 80 questions covering ABIM board review content in
oncology and hematology.



Treatable Cancers & Hematology — Practice Questions


1 Which of the following cancers is considered highly treatable and often curable even
in advanced stages?

A Testicular cancer
B Pancreatic cancer
C Small cell lung cancer
D Glioblastoma


Why A is correct: Testicular cancer is highly treatable and often curable even in advanced
stages with chemotherapy and surgical resection.

B — Pancreatic cancer has a poor prognosis.
C — Small cell lung cancer is aggressive with poor prognosis.
D — Glioblastoma has a very poor prognosis.

, 2 A patient presents with easy bruising, heavy menstrual bleeding, and normal
prothrombin time with mildly prolonged aPTT. What is the most likely diagnosis?

A von Willebrand disease
B Hemophilia A
C Hemophilia B
D Factor XI deficiency


Why A is correct: von Willebrand disease (vWD) presents with easy bruising, heavy
menstrual bleeding, normal PT, and normal to mildly prolonged aPTT.

B — Hemophilia A presents with prolonged aPTT and hemarthroses.
C — Hemophilia B also presents with prolonged aPTT.
D — Factor XI deficiency is rare and presents with bleeding.




3 Which test is considered the gold standard for diagnosing heparin-induced
thrombocytopenia (HIT)?

A Serotonin release assay (SRA)
B ELISA for anti-PF4 antibodies
C Heparin-induced platelet aggregation (HIPA) assay
D Platelet count monitoring


Why A is correct: The serotonin release assay (SRA) is considered the gold standard for HIT
with sensitivity and specificity >95%.

B — ELISA is a screening test with lower specificity.
C — HIPA is specific but less sensitive than SRA.
D — Platelet count monitoring is not diagnostic.

Document information

Uploaded on
August 21, 2026
Number of pages
43
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$12.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
ExamitorMagnus
3.5
(24)
Sold
132
Followers
7
Items
2074
Last sold
8 hours ago




Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions